- Home
- PYPD vs PVL Comparison
PYPD vs PVL Comparison
Compare PYPD & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- PVL
- Stock Information
- Founded
- PYPD 2008
- PVL 2011
- Country
- PYPD Israel
- PVL United States
- Employees
- PYPD N/A
- PVL N/A
- Industry
- PYPD Medical/Dental Instruments
- PVL Oil & Gas Production
- Sector
- PYPD Health Care
- PVL Energy
- Exchange
- PYPD Nasdaq
- PVL Nasdaq
- Market Cap
- PYPD 54.7M
- PVL 57.8M
- IPO Year
- PYPD 2020
- PVL N/A
- Fundamental
- Price
- PYPD $3.80
- PVL $1.86
- Analyst Decision
- PYPD Strong Buy
- PVL
- Analyst Count
- PYPD 5
- PVL 0
- Target Price
- PYPD $12.00
- PVL N/A
- AVG Volume (30 Days)
- PYPD 92.7K
- PVL 69.3K
- Earning Date
- PYPD 11-12-2025
- PVL 01-01-0001
- Dividend Yield
- PYPD N/A
- PVL 19.36%
- EPS Growth
- PYPD N/A
- PVL N/A
- EPS
- PYPD N/A
- PVL 0.09
- Revenue
- PYPD N/A
- PVL $4,598,992.00
- Revenue This Year
- PYPD N/A
- PVL N/A
- Revenue Next Year
- PYPD N/A
- PVL N/A
- P/E Ratio
- PYPD N/A
- PVL $19.78
- Revenue Growth
- PYPD N/A
- PVL 37.78
- 52 Week Low
- PYPD $2.30
- PVL $1.30
- 52 Week High
- PYPD $3.93
- PVL $2.04
- Technical
- Relative Strength Index (RSI)
- PYPD 68.11
- PVL 56.23
- Support Level
- PYPD $3.10
- PVL $1.79
- Resistance Level
- PYPD $3.50
- PVL $1.86
- Average True Range (ATR)
- PYPD 0.18
- PVL 0.05
- MACD
- PYPD 0.06
- PVL 0.01
- Stochastic Oscillator
- PYPD 94.87
- PVL 75.00
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.